Sector revisions Incyte Corporation Sao Paulo

Stocks

Market Closed - Sao Paulo 15:22:47 2026-10-02 EDT			5-day change	1st Jan Change
298.53 ^BRL	-3.99%		-8.34%	+7.73%

10-02	S&P 500 Posts Slight Weekly Drop as Health Care, Financials Weigh	MT
10-01	Wells Fargo Adjusts Price Target on Incyte to $128 From $116, Keeps Equalweight Rating	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							22
	ABBVIE INC.							28
	MERCK & CO., INC.							25
	ROCHE HOLDING AG							19
	NOVARTIS AG							22
	ASTRAZENECA PLC							23
	AMGEN INC.							29
	GILEAD SCIENCES, INC.							26
	NOVO NORDISK A/S							23
	PFIZER INC.							26
	VERTEX PHARMACEUTICALS INCORPORATED							28
	BRISTOL-MYERS SQUIBB COMPANY							24
	MCKESSON CORPORATION							14
	SANOFI							24
	GSK PLC							21
	MODERNA, INC.							18
	REGENERON PHARMACEUTICALS, INC.							26
	MERCK KGAA							14
	Average							23
	Weighted average by Cap.							25